March 11, 2026 · Form 4 insider transaction
Cowan Elvia sold 2,500 shares of Vaxcyte, Inc. at $58.59 per share, a transaction worth $146.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.